Press release from Business Wire
Meridian Bioscience Recognized by Forbes as One of America's 100 Most Trustworthy Companies
Thursday, March 28, 2013
Meridian Bioscience Recognized by Forbes as One of America's 100 Most Trustworthy Companies11:00 EDT Thursday, March 28, 2013
CINCINNATI (Business Wire) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has been recognized by Forbes as one of America's 100 Most Trustworthy Companies. The list is selected following a comprehensive evaluation of governance and accounting practices of candidate companies having market capitalization over $250 million. The rankings are based on data from GMI Ratings (GMI) that looks at over 60 governance and accounting measures. The list reflects companies that have consistently demonstrated transparent and conservative accounting practices and solid corporate governance and management.
John A. Kraeutler, Chief Executive Officer, stated, “Over the years we have built a biomedical business that helps ensure better outcomes for patients suffering from acute infectious diseases and, that supports thousands of researchers as they work to develop new diagnostics and new therapies to improve and provide access to quality healthcare. Meridian Bioscience is committed to building shareholder value and trust as it operates under the highest standards of quality, compliance and governance. Sincere thanks to every Meridian Bioscience employee and to our Board of Directors for their commitment to these goals.”
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral and respiratory infections. Meridian's diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents, specialty biologicals and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products and technologies to hospitals, reference laboratories, research centers, diagnostics manufacturers and biotech companies in more than 60 countries around the world. The Company's shares are traded on NASDAQ's Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.
Meridian Bioscience, Inc.
John A. Kraeutler, Chief Executive Officer, 513-271-3700